Thermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll - Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Beats Q1 Estimates, Lowers Full-Year Forecast As Tariffs And Costs Take A Toll - Thermo Fisher Scientific (NYSE:TMO)

Thermo Fisher Scientific Inc. (NYSE:TMO) on Wednesday reported first-quarter 2025 adjusted earnings per share of $5.15, beating the street view of $5.10. Quarterly sales of $10.36 billion, almost flat year over year, outpaced the analyst consensus estimate of $10.23 billion. Organic revenue growth was 1%. "We delivered very strong performance in the first quarter in a more uncertain macroeconomic environment, and I'm incredibly proud of our team…

Thermo Fisher invests $2B in US to counter tariffs, funding cuts

Amid the Trump administration's tariffs and government funding cuts, Thermo Fisher is investing $2 billion over the next four years in US manufacturing and R&D.

Dauntless Investment Group LLC Makes New Investment in Thermo Fisher Scientific Inc. (NYSE:TMO)

Dauntless Investment Group LLC bought a new stake in shares of Thermo Fisher Scientific Inc. (NYSE:TMO – Free Report) in the fourth quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 461 shares of the medical research company’s stock, valued at approximately $240,000. A number of other hedge […]